Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study
Journal of Alzheimer’s Disease · 13.02.2024 · 97 (4) · 1841-1850
DOI: 10.3233/jad-230718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 01.02.2024. Verfasst von Erika Vestin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Caring Sciences, Clinical Geriatrics, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Herpes Simplex, Herpesvirus 1, Human, Cytomegalovirus Infections, Alzheimer Disease. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Background
Evidence indicates that herpes simplex virus (HSV) participates in the pathogenesis of Alzheimer’s disease (AD).
Objective
We investigated AD and dementia risks according to the presence of herpesvirus antibodies in relation to anti-herpesvirus treatment and potential APOE ɛ4 carriership interaction.
Methods
This study was conducted with 1002 dementia-free 70-year-olds living in Sweden in 2001–2005 who were followed for 15 years. Serum samples were analyzed to detect anti-HSV and anti-HSV-1 immunoglobulin (Ig) G, anti-cytomegalovirus (CMV) IgG, anti-HSV IgM, and anti-HSV and anti-CMV IgG levels. Diagnoses and drug prescriptions were collected from medical records. Cox proportional-hazards regression models were applied.
Results
Cumulative AD and all-cause dementia incidences were 4% and 7%, respectively. Eighty-two percent of participants were anti-HSV IgG carriers, of whom 6% received anti-herpesvirus treatment. Anti-HSV IgG was associated with a more than doubled dementia risk (fully adjusted hazard ratio = 2.26, p = 0.031). No significant association was found with AD, but the hazard ratio was of the same magnitude as for dementia. Anti-HSV IgM and anti-CMV IgG prevalence, anti-herpesvirus treatment, and anti-HSV and -CMV IgG levels were not associated with AD or dementia, nor were interactions between anti-HSV IgG and APOE ɛ4 or anti-CMV IgG. Similar results were obtained for HSV-1.
Conclusions
HSV (but not CMV) infection may be indicative of doubled dementia risk. The low AD incidence in this cohort may have impaired the statistical power to detect associations with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health and Caring Sciences, Clinical Geriatrics, Uppsala University, Uppsala, Sweden.
- Centre for Clinical Research, Västmanland and County Hospital, Uppsala University, Västerås, Sweden.
- Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
- Department of Medical Sciences, Acute and Internal Medicine, Uppsala University, Uppsala, Sweden.
- Department of Community Medicine and Rehabilitation, Geriatric Medicine, Umeå University, Umeå, Sweden.
Zitieren
APA
Vestin, E., Boström, G., Olsson, J., Elgh, F., Lind, L., Kilander, L., Lövheim, H., & Weidung, B. (2024). Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study. Journal of Alzheimer’s Disease, 97(4), 1841-1850. https://doi.org/10.3233/jad-230718
Vancouver
Vestin E, Boström G, Olsson J, Elgh F, Lind L, Kilander L, et al. Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study. Journal of Alzheimer’s Disease. 2024;97(4):1841-1850. doi:10.3233/jad-230718
BibTeX
@article{Vestin2024,
author = {Vestin, Erika and Boström, Gustaf and Olsson, Jan and Elgh, Fredrik and Lind, Lars and Kilander, Lena and Lövheim, Hugo and Weidung, Bodil},
title = {Herpes Simplex Viral Infection Doubles the Risk of Dementia in a Contemporary Cohort of Older Adults: A Prospective Study},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
volume = {97},
number = {4},
pages = {1841--1850},
doi = {10.3233/jad-230718}
}
EUVIMED